# Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS

> **NCT06159114** · PHASE4 · COMPLETED · sponsor: **Xintian Pharmaceutical** · enrollment: 246 (actual)

## Conditions studied

- Chronic Prostatitis

## Interventions

- **DRUG:** Ningmitai capsule
- **DRUG:** Celecoxib capsule
- **DRUG:** Ningmitai placebo
- **DRUG:** Celecoxib placebo

## Key facts

- **NCT ID:** NCT06159114
- **Lead sponsor:** Xintian Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-19
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06159114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06159114, "Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06159114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*